
10x Genomics TXG
$ 28.31
1.13%
Quarterly report 2026-Q1
added 05-16-2026
10x Genomics DPO Ratio 2011-2026 | TXG
Annual DPO Ratio 10x Genomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.5 | 26.6 | 32.5 | 59 | 54.3 | 55.4 | 77.9 | - | 188 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 188 | 23.5 | 64.7 |
Quarterly DPO Ratio 10x Genomics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.3 | 31.9 | 24.8 | 33.5 | 47.8 | 38.7 | 19.2 | - | 28.3 | 64.7 | - | - | 75.2 | 65 | - | 61.8 | 295 | 54.3 | - | 29.8 | 42.8 | 53.6 | - | 76.8 | 79.2 | 71.3 | - | 76.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 295 | 19.2 | 62.2 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
103 | - | - | $ 27.9 B | ||
|
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M | ||
|
Evolent Health
EVH
|
19.3 | $ 3.95 | 1.28 % | $ 451 M | ||
|
Computer Programs and Systems
CPSI
|
38.7 | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | ||
|
HealthEquity
HQY
|
12.1 | $ 87.99 | -2.79 % | $ 7.58 B | ||
|
iCAD
ICAD
|
112 | - | - | $ 102 M | ||
|
GoodRx Holdings
GDRX
|
106 | $ 2.92 | -1.68 % | $ 1.04 B | ||
|
Akerna Corp.
KERN
|
5.62 | - | - | $ 161 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
32.6 | - | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | ||
|
1Life Healthcare
ONEM
|
14 | - | - | $ 3.37 B | ||
|
NextGen Healthcare
NXGN
|
14.5 | - | - | $ 1.6 B | ||
|
Premier
PINC
|
28.6 | - | - | $ 2.33 B | ||
|
Health Catalyst
HCAT
|
23.8 | $ 1.38 | -1.43 % | $ 96.5 M | ||
|
OptimizeRx Corporation
OPRX
|
19.3 | $ 5.19 | 1.76 % | $ 96.3 M | ||
|
Schrödinger
SDGR
|
35.6 | $ 15.2 | 7.34 % | $ 1.12 B | ||
|
Phreesia
PHR
|
43.7 | $ 9.86 | 4.34 % | $ 589 M | ||
|
R1 RCM
RCM
|
5.63 | - | - | $ 3.81 B | ||
|
Teladoc Health
TDOC
|
19.2 | $ 7.61 | 1.33 % | $ 1.34 B | ||
|
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | ||
|
NantHealth
NH
|
86.1 | - | -46.64 % | $ 10.4 M | ||
|
SCWorx Corp.
WORX
|
43.2 | - | - | $ 7.71 M | ||
|
American Well Corporation
AMWL
|
10.4 | $ 9.83 | 3.91 % | $ 158 M | ||
|
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M | ||
|
HealthStream
HSTM
|
24.5 | $ 24.97 | 1.38 % | $ 750 M | ||
|
Omnicell
OMCL
|
25.7 | $ 44.14 | -1.3 % | $ 2.03 B | ||
|
Progyny
PGNY
|
166 | $ 25.56 | -0.51 % | $ 2.18 B | ||
|
So-Young International
SY
|
10.8 | $ 1.95 | - | $ 152 M | ||
|
Veeva Systems
VEEV
|
15.9 | $ 174.34 | 6.06 % | $ 28.5 B | ||
|
Zhongchao
ZCMD
|
31 | $ 0.17 | -69.09 % | $ 581 K |